Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 564 Records) |
| Query Trace: Colorectal Neoplasms and Egfr[original query] |
|---|
| Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer. Archives of medical science : AMS 2022 9 18 (5): 1221-1230. Bo?yk Aleksandra, Krawczyk Pawe?, Reszka Katarzyna, Krukowska Kinga, Kolak Agnieszka, Ma?dziuk S?awomir, Wojas-Krawczyk Kamila, Ramlau Rodryg, Milanowski Janu |
| CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice. Tumori 2022 9 3008916221122554. D'Onofrio Raffaella, Caputo Francesco, Prampolini Francesco, Spallanzani Andrea, Gelsomino Fabio, Bettelli Stefania, Manfredini Samantha, Reggiani Bonetti Luca, Carotenuto Pietro, Bocconi Alessandro, Dominici Massimo, Luppi Gabriele, Salati Massimilia |
| RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAF metastatic colorectal cancer. Nature medicine 2022 9 28 (10): 2162-2170. Elez Elena, Ros Javier, Fernández Jose, Villacampa Guillermo, Moreno-Cárdenas Ana Belén, Arenillas Carlota, Bernatowicz Kinga, Comas Raquel, Li Shanshan, Kodack David Philip, Fasani Roberta, Garcia Ariadna, Gonzalo-Ruiz Javier, Piris-Gimenez Alejandro, Nuciforo Paolo, Kerr Grainne, Intini Rossana, Montagna Aldo, Germani Marco Maria, Randon Giovanni, Vivancos Ana, Smits Ron, Graus Diana, Perez-Lopez Raquel, Cremolini Chiara, Lonardi Sara, Pietrantonio Filippo, Dienstmann Rodrigo, Tabernero Josep, Toledo Rodrigo |
| Prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project. Cancer treatment and research communications 2022 Aug 33 100623. Bridgewater John, Jiao Xiaolong, Parimi Mounika, Flach Clare, Stratford Jeran, Kamburov Atanas, Schmitz Arndt A, Zong Jihong, Reeves John A, Keating Karen, Bruno Amanda, Fellous Marc, Pereira Mariana Buongermino, Bazhenova Lyudmi |
| Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 8 41 (3): 485-496. Topham James T, O'Callaghan Chris J, Feilotter Harriet, Kennecke Hagen F, Lee Young S, Li Weimin, Banks Kimberly C, Quinn Katie, Renouf Daniel J, Jonker Derek J, Tu Dongsheng, Chen Eric X, Loree Jonathan |
| Distinct NSCLC EGFR Variants in a Family With Li-Fraumeni Syndrome: Case Report. JTO clinical and research reports 2022 7 3 (8): 100368. Edmondson Shelby, von Itzstein Mitchell S, Reys Brian, Mayer Melissa, Gagan Jeffrey, Gerber David |
| Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 2022 6 6 e2100289. Gerratana Lorenzo, Movarek Michael, Wehbe Firas, Katam Neelima, Mahalingam Devalingam, Donahue Jeannine, Shah Ami, Chae Young K, Mulcahy Mary, Tsarwhas Dean, Villaflor Victoria, Kalyan Aparna, Hussein Maha, Patel Jyoti, Chandra Sunandana, Platanias Leonidas C, Gradishar William, Cristofanilli Massimo, Behdad Am |
| Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer. Targeted oncology 2022 Jun . Tan Elaine S, Fan Wenyi, Knepper Todd C, Schell Michael J, Sahin Ibrahim H, Fleming Jason B, Xie H |
| Somatic targeted mutation profiling of colorectal cancer precursor lesions. BMC medical genomics 2022 Jun 15 (1): 143. Dos Santos Wellington, Dos Reis Mariana Bisarro, Porto Jun, de Carvalho Ana Carolina, Matsushita Marcus, Oliveira Gabriela, Syrjänen Kari, Reis Rui Manuel, Guimarães Denise Peixo |
| Molecular mechanisms underlying the resistance of BRAF V600E-mutant metastatic colorectal cancer to EGFR/BRAF inhibitors. Therapeutic advances in medical oncology 2022 6 14 17588359221105022. Xu Ting, Wang Xicheng, Wang Zhenghang, Deng Ting, Qi Changsong, Liu Dan, Li Yanyan, Ji Congcong, Li Jian, Shen L |
| Germline Polymorphisms in Genes Involved in the Antioxidant System Predict the Efficacy of Cetuximab in Metastatic Colorectal Cancer Patients Enrolled in FIRE-3 Trial. Clinical colorectal cancer 2022 May . Arai Hiroyuki, Millstein Joshua, Yang Yan, Stintzing Sebastian, Wang Jingyuan, Battaglin Francesca, Kawanishi Natsuko, Jayachandran Priya, Soni Shivani, Zhang Wu, Heinemann Volker, Lenz Heinz-Jos |
| Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience. ESMO open 2022 6 7 (3): 100506. Boccaccino A, Borelli B, Intini R, Antista M, Bensi M, Rossini D, Passardi A, Tamberi S, Giampieri R, Antonuzzo L, Noto L, Roviello G, Zichi C, Salati M, Puccini A, Noto C, Parisi A, Rihawi K, Persano M, Crespi V, Libertini M, Giordano M, Moretto R, Lonardi S, Cremolini |
| Characterizing the KRAS G12C mutation in metastatic colorectal cancer: a population-based cohort and assessment of expression differences in The Cancer Genome Atlas. Therapeutic advances in medical oncology 2022 6 14 17588359221097940. Li Meredith, Keshavarz-Rahaghi Faeze, Ladua Gale, Swanson Lucas, Speers Caroline, Renouf Daniel J, Lim Howard J, Davies Janine M, Gill Sharlene, Stuart Heather C, Yip Stephen, Loree Jonathan |
| Multivariate Risk Analysis of RAS, BRAF and EGFR Mutations Allelic Frequency and Coexistence as Colorectal Cancer Predictive Biomarkers. Cancers 2022 Jun 14 (11): . Ionescu Adriana, Bilteanu Liviu, Geicu Ovidiu Ionut, Iordache Florin, Stanca Loredana, Pisoschi Aurelia Magdalena, Miron Adrian, Serban Andreea Iren, Calu Valent |
| Mucinous Histology Is Associated with Resistance to Anti-EGFR Therapy in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer. The oncologist 2022 5 27 (2): 104-109. Wang Chongkai, Sandhu Jaideep, Fakih Marw |
| Epithelial TGF? engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features. Nature communications 2022 12 13 (1): 7551. Flanagan Dustin J, Amirkhah Raheleh, Vincent David F, Gunduz Nuray, Gentaz Pauline, Cammareri Patrizia, McCooey Aoife J, McCorry Amy M B, Fisher Natalie C, Davis Hayley L, Ridgway Rachel A, Lohuis Jeroen, Leach Joshua D G, Jackstadt Rene, Gilroy Kathryn, Mariella Elisa, Nixon Colin, Clark William, Hedley Ann, Markert Elke K, Strathdee Douglas, Bartholin Laurent, Redmond Keara L, Kerr Emma M, Longley Daniel B, Ginty Fiona, Cho Sanghee, Coleman Helen G, Loughrey Maurice B, Bardelli Alberto, Maughan Timothy S, Campbell Andrew D, Lawler Mark, Leedham Simon J, Barry Simon T, Inman Gareth J, van Rheenen Jacco, Dunne Philip D, Sansom Owen |
| Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer. Clinical colorectal cancer 2022 12 . Ten Hoorn Sanne, Mol Linda, Sommeijer Dirkje W, Nijman Lisanne, van den Bosch Tom, de Back Tim R, Ylstra Bauke, van Dijk Erik, van Noesel Carel J M, Reinten Roy J, Nagtegaal Iris D, Koopman Miriam, Punt Cornelis J A, Vermeulen Lou |
| Clinical and molecular characteristics of kinase domain duplications across diverse cancer types in the Chinese population. Cancer medicine 2022 11 . Lai Xiaojing, Yu Ruoying, Ou Qiuxiang, Bao Hua, Wu Xue, Shao Yang, Li Yang, Zhang Ying, Ding Qingqi |
| Molecular Typing and Clinical Characteristics of Synchronous Multiple Primary Colorectal Cancer. JAMA network open 2022 11 5 (11): e2243457. Zhao Yandong, Wu Jingjing, Pei Fengyun, Zhang Yanxiang, Bai Shaomei, Shi Lishuo, Zhang Xiang, Ma Jingjiao, Zhao Ximeng, Ma Tonghui, Wang Jianping, Huang Meijin, Fan Xinjuan, Huang J |
| Liquid biopsy to detect resistance mutations against anti-epidermal growth factor receptor therapy in metastatic colorectal cancer. World journal of gastrointestinal oncology 2022 10 14 (9): 1654-1664. Valenzuela Guillermo, Burotto Mauricio, Marcelain Katherine, González-Montero Jai |
| Identification of immune-related mechanisms of cetuximab induced skin toxicity in colorectal cancer patients. PloS one 2022 17 (10): e0276497. Park Jin Hyun, Kim Mi Young, Choi In Sil, Kim Ji-Won, Kim Jin Won, Lee Keun-Wook, Kim Jin-S |
| [Laser microdissection for the analysis of molecular heterogeneity in colorectal cancer]. Pathologie (Heidelberg, Germany) 2022 10 43 (Suppl 1): 36-41. Maag Nathalie, Arndt Annette, Steinestel Konr |
| Identification of KRAS mutation and HER2 expression in Indonesian colorectal cancer population: a cross-sectional study. Annals of medicine and surgery (2012) 2023 5 85 (5): 1761-1768. Reno Rudiman, Alma Wijaya, Yunia Sribudiani, Hardi Siswo Soedjana, Hesti Lina Wiraswati, Etis Pramaswati, Prapanca Nugraha, Kiki Lukm |
| A single-center retrospective analysis of the efficacy and safety of a modified regimen of irinotecan plus S-1 (IRIS) with molecular targeting agents as second-line chemotherapy in Japanese patients with recurrent or nonresectable colorectal cancer. Journal of gastrointestinal oncology 2023 5 14 (2): 663-675. Shigeo Higami, Masaya Mukai, Daiki Yokoyama, Syuji Uda, Rin Abe, Nana Mamuro, Kyoko Kishima, Sayuri Hasegawa, Takayuki Tajima, Eiji Nomura, Hiroyasu Makuuc |
| Panitumumab Plus Trifluridine-Tipiracil as Anti-Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial. JAMA oncology 2023 5 . Stefania Napolitano, Vincenzo De Falco, Giulia Martini, Davide Ciardiello, Erika Martinelli, Carminia Maria Della Corte, Lucia Esposito, Vincenzo Famiglietti, Alessandra Di Liello, Antonio Avallone, Claudia Cardone, Alfonso De Stefano, Vincenzo Montesarchio, Maria Giulia Zampino, Roberto Bordonaro, Mario Scartozzi, Daniele Santini, Massimo Di Maio, Ferdinando De Vita, Lucia Altucci, Francesca Marrone, Fortunato Ciardiello, Teresa Troia |
| Genomic profiles of Indonesian colorectal cancer patients. F1000Research 2023 5 11 443. Murdani Abdullah, Sofy Meilany, Hidayat Trimarsanto, Safarina G Malik, Ninik Sukartini, Firhat Idrus, Saskia A Nursyirwan, Virly N Muzellina, Rabbinu R Pribadi, Amanda P Utari, Hasan Maulahela, Ari F Sy |
| Genomic landscape and survival analysis of ctDNA "neo-RAS wild-type" patients with originally RAS mutant metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1160673. Nicolazzo Chiara, Magri Valentina, Marino Luca, Belardinilli Francesca, Di Nicolantonio Federica, De Renzi Gianluigi, Caponnetto Salvatore, De Meo Michela, Giannini Giuseppe, Santini Daniele, Cortesi Enrico, Gazzaniga Pao |
| Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer. Frontiers in oncology 2023 4 13 1147497. Mauri Gianluca, Patelli Giorgio, Gori Viviana, Lauricella Calogero, Mussolin Benedetta, Amatu Alessio, Bencardino Katia, Tosi Federica, Bonazzina Erica, Bonoldi Emanuela, Bardelli Alberto, Siena Salvatore, Sartore-Bianchi Andr |
| Pretreatment Plasma Circulating Tumor DNA RAS/BRAF Mutational Status in Refractory Metastatic Colorectal Cancer Patients Who Are Candidates for Anti-EGFR Rechallenge Therapy: A Pooled Analysis of the CAVE and VELO Clinical Trials. Cancers 2023 4 15 (7): . Ciardiello Davide, Napolitano Stefania, Famiglietti Vincenzo, Esposito Lucia, De Falco Vincenzo, Di Liello Alessandra, Avallone Antonio, Maiello Evaristo, Pietrantonio Filippo, Cremolini Chiara, Zampino Maria Giulia, Fazio Nicola, Troiani Teresa, Martinelli Erika, Ciardiello Fortunato, Martini Giul |
| Plasmatic BRAF-V600E allele fraction as a prognostic factor in metastatic colorectal cancer treated with BRAF combinatorial treatments. Annals of oncology : official journal of the European Society for Medical Oncology 2023 3 . Ros J, Matito J, Villacampa G, Comas R, Garcia A, Martini G, Baraibar I, Saoudi N, Salvà F, Martin Á, Antista M, Toledo R, Martinelli E, Pietrantonio F, Boccaccino A, Cremolini C, Dientsmann R, Tabernero J, Vivancos A, Elez |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 30, 2023
- Content source: